At a NATCO lab in Hyderabad. Bayer is contesting the first ever compulsory license given to NATCO to produce Nexavar, an anti-cancer drug, at 3% the cost.
READ AT
http://www.thealternative.in/society/are-drug-patents-impeding-access-to-affordable-medicine/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE